We are live on
!
Find out more
ACM
Axel Capital Management Portfolio holdings
AUM
$47.4M
1-Year Est. Return
2.75%
This Fund
S&P 500
This Quarter
Est. Return
+3.28%
1 Year Est. Return
-2.75%
3 Year Est. Return
+193.8%
5 Year Est. Return
+305.5%
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$75.8M
(-40%)
Cap. Flow
-$79.9M
Cap. Flow
% of AUM
-71.01%
Top 10 Holdings %
Top 10 Hldgs %
95.2%
Holding
19
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$78M |
| 2 |
Eli Lilly
LLY
|
+$1.46M |
| 3 |
Mastercard
MA
|
+$473K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 7.44% |
| 2 | Healthcare | 4.25% |
| 3 | Financials | 3.35% |
| 4 | Real Estate | 2.69% |
| 5 | Technology | 1.96% |
Similar funds
CCS
NRC
SJIA
HA
JI
DFAM
AI
HJMC
Axel Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Axel Capital Management held 19 positions worth $113M, down 40% from $188M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Axel Capital Management withdrew a net $79.9M in Q2 2016, closing 2 positions and reducing 1 holding. Its most notable exit was Eli Lilly, an estimated $1.46M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 7.4% of assets, up from 4.1% a quarter earlier, followed by Healthcare and Financials.
- Axel Capital Management's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $78M.
- Axel Capital Management fully exited Eli Lilly in Q2 2016, selling an estimated $1.46M.
- Axel Capital Management's ten largest holdings make up 95% of its $113M portfolio in Q2 2016.
- Axel Capital Management opened 0 new positions and closed 2 in Q2 2016.
- Axel Capital Management's portfolio value fell 40% quarter-over-quarter to $113M.
Based on Axel Capital Management's 13F filing for Q2 2016, filed 11 Aug 2016.